BF
IBB icon

BOK Financial’s iShares Biotechnology ETF IBB Stock Holding History

BOK Financial’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Hold
1,087
– – ﹤0.01% 673
2026
Q1 		$184K Hold
1,087
– – ﹤0.01% 688
2025
Q4 		$183K Buy
1,087
+41
+4% +$6.66K ﹤0.01% 699
2025
Q3 		$151K Buy
1,046
+4
+0.4% +$546 ﹤0.01% 726
2025
Q2 		$132K Sell
1,042
-76
-7% -$9.33K ﹤0.01% 741
2025
Q1 		$143K Sell
1,118
-224
-17% -$30.4K ﹤0.01% 732
2024
Q4 		$178K Sell
1,342
-1
-0.1% -$141 ﹤0.01% 702
2024
Q3 		$192K Hold
1,343
– – ﹤0.01% 698
2024
Q2 		$184K Hold
1,343
– – ﹤0.01% 759
2024
Q1 		$184K Sell
1,343
-470
-26% -$64.2K ﹤0.01% 729
2023
Q4 		$246K Hold
1,813
– – ﹤0.01% 642
2023
Q3 		$206K Buy
1,813
+6
+0.3% +$763 ﹤0.01% 637
2023
Q2 		$229K Buy
1,807
+470
+35% +$61.1K ﹤0.01% 631
2023
Q1 		$173K Buy
+1,337
New +$175K ﹤0.01% 683
2022
Q2 		– Sell
-1,985
Closed -$259K – 935
2022
Q1 		$259K Buy
1,985
+650
+49% +$84.7K ﹤0.01% 866
2021
Q4 		$203K Buy
1,335
+68
+5% +$10.5K ﹤0.01% 936
2021
Q3 		$205K Buy
+1,267
New +$213K ﹤0.01% 909
2021
Q1 		$279K Hold
1,852
– – 0.01% 802
2020
Q4 		$281K Hold
1,852
– – 0.01% 785
2020
Q3 		$251K Hold
1,852
– – 0.01% 765
2020
Q2 		$253K Buy
+1,852
New +$236K 0.01% 764
2020
Q1 		– Sell
-2,225
Closed -$268K – 870
2019
Q4 		$268K Hold
2,225
– – 0.01% 819
2019
Q3 		$221K Hold
2,225
– – 0.01% 841
2019
Q2 		$243K Hold
2,225
– – 0.01% 824
2019
Q1 		$249K Sell
2,225
-300
-12% -$32.9K 0.01% 817
2018
Q4 		$243K Sell
2,525
-1,011
-29% -$107K 0.01% 777
2018
Q3 		$431K Buy
3,536
+13
+0.4% +$1.53K 0.01% 719
2018
Q2 		$387K Sell
3,523
-253
-7% -$27.1K 0.01% 734
2018
Q1 		$403K Sell
3,776
-10
-0.3% -$1.11K 0.01% 695
2017
Q4 		$404K Sell
3,786
-159
-4% -$17K 0.01% 715
2017
Q3 		$439K Buy
3,945
+450
+13% +$48.1K 0.01% 687
2017
Q2 		$361K Buy
3,495
+330
+10% +$32.5K 0.01% 702
2017
Q1 		$309K Sell
3,165
-576
-15% -$55.1K 0.01% 760
2016
Q4 		$331K Sell
3,741
-105
-3% -$9.56K 0.01% 739
2016
Q3 		$371K Hold
3,846
– – 0.01% 709
2016
Q2 		$330K Sell
3,846
-600
-13% -$53.8K 0.01% 696
2016
Q1 		$387K Buy
4,446
+600
+16% +$53.7K 0.01% 639
2015
Q4 		$434K Buy
3,846
+570
+17% +$61.9K 0.02% 607
2015
Q3 		$332K Hold
3,276
– – 0.01% 658
2015
Q2 		$403K Sell
3,276
-15
-0.5% -$1.8K 0.01% 624
2015
Q1 		$377K Buy
+3,291
New +$363K 0.01% 620
2014
Q4 		– Sell
-3,531
Closed -$322K – 737
2014
Q3 		$322K Sell
3,531
-90
-2% -$7.9K 0.01% 684
2014
Q2 		$310K Buy
3,621
+810
+29% +$63.8K 0.01% 758
2014
Q1 		$222K Hold
2,811
– – 0.01% 824
2013
Q4 		$213K Sell
2,811
-981
-26% -$69.6K 0.01% 829
2013
Q3 		$265K Sell
3,792
-33
-0.9% -$2.16K 0.01% 727
2013
Q2 		$221K Buy
+3,825
New +$221K 0.01% 746

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

BOK Financial's IBB Position: Q2 2026 in Review

BOK Financial held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,087 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #673.

BOK Financial first reported a position in IBB in Q2 2013 and has held it in 47 quarters since. The position peaked at $439K in Q3 2017. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • BOK Financial held 1,087 shares of iShares Biotechnology ETF worth $207K as of Q2 2026.
  • BOK Financial left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of BOK Financial's portfolio in Q2 2026, its #673 holding.
  • BOK Financial first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 47 quarters since.
  • BOK Financial's iShares Biotechnology ETF position peaked at $439K in Q3 2017.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.